logo

Rumi Scientific

Rumi Scientific's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Rumi Scientific's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@rumiscientific.com
 

Steven A. Goldman

steve-goldman

Stephen A. Goldman, M.D., Ph.D., SAB Member

 

Dr. Steven Goldman is the URMC Distinguished Professor of Neuroscience and Neurology, and co-Director of Rochester’s Center for Translational Neuromedicine. Dr. Goldman remains active clinically and is board certified in neuro-oncology. He serves on standing committees of the NIH, and has served as a voting member of the FDA Cellular, Tissue and Gene Therapy Advisory Committee. Dr. Goldman has published over 250 papers, over 100 as first or senior author, and holds over 30 patents in his field. His research interests are cell genesis and regeneration in the adult brain, with a focus on the use of stem and progenitor cells in both modeling and treating demyelinating and neurodegenerative diseases.


I would like to learn about Rumi Scientific’s novel discoveries to treat genetic diseases.